Browse

Comprehensive gene expression analysis for exploring the association between glucose metabolism and differentiation of thyroid cancer

Cited 0 time in Web of Science Cited 0 time in Scopus
Authors
Suh, Hoon Young; Choi, Hongyoon; Paeng, Jin Chul; Cheon, Gi Jeong; Chung, June-Key; Kang, Keon Wook
Issue Date
2019-12-30
Publisher
BMC
Citation
BMC Cancer, 19(1):1260
Keywords
Glucose metabolismThyroid cancerTumor differentiationGlycolysisGLUT
Abstract
Background
The principle of loss of iodine uptake and increased glucose metabolism according to dedifferentiation of thyroid cancer is clinically assessed by imaging. Though these biological properties are widely applied to appropriate iodine therapy, the understanding of the genomic background of this principle is still lacking. We investigated the association between glucose metabolism and differentiation in advanced thyroid cancer as well as papillary thyroid cancer (PTC).

Methods
We used RNA sequencing of 505 patients with PTC obtained from the Cancer Genome Archives and microarray data of poorly-differentiated and anaplastic thyroid cancer (PDTC/ATC). The signatures of GLUT and glycolysis were estimated to assess glucose metabolic profiles. The glucose metabolic profiles were associated with tumor differentiation score (TDS) and BRAFV600E mutation status. In addition, survival analysis of glucose metabolic profiles was performed for predicting recurrence-free survival.

Results
In PTC, the glycolysis signature was positively correlated with TDS, while the GLUT signature was inversely correlated with TDS. These correlations were significantly stronger in the BRAFV600E negative group than the positive group. Meanwhile, both GLUT and glycolysis signatures were negatively correlated with TDS in advanced thyroid cancer. The high glycolysis signature was significantly associated with poor prognosis in PTC in spite of high TDS. The glucose metabolic profiles are intricately associated with tumor differentiation in PTC and PDTC/ATC.

Conclusions
As glycolysis was an independent prognostic marker, we suggest that the glucose metabolism features of thyroid cancer could be another biological progression marker different from differentiation and provide clinical implications for risk stratification.

Trial registration
Not applicable.
ISSN
1471-2466
Language
English
URI
https://doi.org/10.1186/s12885-019-6482-7

http://hdl.handle.net/10371/164890
Files in This Item:
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Nuclear Medicine (핵의학전공)Journal Papers (저널논문_핵의학전공)
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse